Unfortunately, the original version of this article [1] contained an error. After publication the authors became aware of the mistakes in computing the proportions of excess direct medical costs and indirect productivity-related losses in the Abstract, Results and Discussion (described as follows). The proportion of excess direct medical costs and indirect productivity-related losses in 2010 were updated from 42 to 26 % and 58 % to 74 % respectively. Likewise, the share of indirect costs in 2050 rose to 81 % instead of 65 % as previously written with the direct medical cost reduced to 19 % instead of 35 %. In the Discussion section, in the U.S., 72 % of the total economic burden for diabetes patients is direct medical costs, compared to 26 % instead of 42 % in Singapore.
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In making these changes we became aware of two other errors that had not been corrected at final draft stage of the publishing process. These are described below:
i. Under the sub-section Cost estimation of absenteeism from Methods section, the average wage for Singaporean residents in 2010 that was used in the analysis was US$3,446 for males and US$2525 for females instead of US$3,004.
ii. The values in the Sensitivity analyses sub-section from
Results section were the incremental differences from baseline values. Hence, the paragraph should read:
The total cost per patient among 20-29 years old would increase by up to US$12,361 from base case estimate while those among 30-39 would increase by up to US$5,533 and decrease by up to US$2,520 from base case estimate. Wage growth was the most influential parameter on total cost per patient in 2050 for those aged 40-59 years old. The total cost per patient among 40-49 years old would grow by up to US$4,993 and reduce by up to US$3,407 from base case estimate while those among 50-59 would grow by up to US$5,572 and reduce by up to US$3,802 from base case estimate. Lastly, for those aged 60-69, the excess direct medical cost of diabetes was the most influential on total cost per patient in 2050 with cost that would increase by up to US$4,966 and reduce by up to US$988 from base case estimate.
None of the conclusions reached in the uncorrected version of the paper has been revised in the light of these changes.
